Ketanserin Facts As Well As The Misconceptions

16 Recently, in a single-center series of 181 patients receiving RC and LND up to the inferior mesenteric artery with one or two positive nodes, Bruins et?al. found that 4% LN-d was able to independently predict recurrence-free survival.9 The cut-off of 4% is not reproducible by excluding patients with more than two positive nodes; however, Bruins et?al. highlighted the potential therapeutic role of an extended LND (up or above the aortic bifurcation) in patients with low-volume metastatic-node disease, but it also shed light on the importance of extended LND in determining the clinical relevance of LN-d. In confirmation of this concept, Jeong et?al. reported 18% LN-d as the only variable with an independent role in predicting CSS of 130?pN+ patients.17 In that series, the median LN-c was 15, and the authors found that when a small https://en.wikipedia.org/wiki/Ketanserin number of nodes was removed, pN status was a better predictor than LN-d. In the series published by Osawa et?al., 60?pN+ patients were selected; with a median number of 12 nodes removed, the most informative LN-d cut-off was 25%.18 In 2008, Wright et?al. published a population-based study, collecting data from http://www.selleckchem.com/products/midostaurin-pkc412.html 1260 patients in the Surveillance Epidemiology and End Results database.19 The authors found that the lowest risk of death was in the 0�C12.5% LN-d quartile, and they found no interaction among number of lymph nodes, age, LN-c and LN-d. They concluded that the previously published threshold of 20% might be too high, because a 12.5% cut-off strongly predicts survival, even compared with the 12.5�C25% interval. In 2008, Wiesner et?al. published a study on the extent of pelvic LND and the prognostic value of LN-d. The authors included 46 node-positive patients from a group of 152 patients in the study, and the LN-d cut-off identified was 11%, which correlates with previous considerations, as the median number of lymph nodes removed was 33.20 In a multicenter retrospective study, Kassouf et?al. first showed an improved outcome prediction by categorizing LN-d according to a tertiary (41%) instead of the usual binary distribution. Despite the large cohort of patients (1038?pN+), the authors acknowledged the lack http://www.selleckchem.com/products/liproxstatin-1.html of a prospective standardized template for LND across surgeons and centers as the main study drawback. In fact, LND was defined as ��limited�� or ��more extensive�� when